U.S. pharma big copyright scrapped two experimental weight loss capsules final year—a the moment-each day pill, lotiglipron, on account of elevated liver enzymes and a 2 times-day-to-day capsule, danuglipron, on account of solid Unintended effects—but CEO Albert Bourla has said the company is set to “Participate in and get” in the obesity s